ANNUAL RESULTS
Emcure Pharmaceuticals Ltd.
BSE
Jun 16, 09:58
1333.00
-29.70 ( -2.18%)
Volume
1315
Prev. Close
1362.70
Open Price
1320.05
Bid Price(Qty.)
1335.05 (9)
Offer Pr.(Qty.)
1338.25 (16)
NSE
Jun 16, 09:44
1350.50
-10.90 ( -0.80%)
Volume
10098
Prev. Close
1361.40
Open Price
1362.20
Bid Price(Qty.)
1349.60 (11)
Offer Pr.(Qty.)
1351.20 (11)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE168P01015
|
Market Cap. ( ₹ in Cr. )
|
25593.10
|
P/BV
|
6.21
|
Book Value ( ₹ )
|
217.34
|
|
BSE Code
|
544210
|
52 Week High/Low ( ₹ )
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.56
|
|
NSE Code
|
EMCUREEQ
|
Book Closure
|
|
EPS ( ₹ )
|
35.95
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 4381.92 | 3468.98 | 3088.99 | 3378.93 | 3127.20 |
| Other Operating Income | 0.00 | 28.68 | 18.09 | 8.32 | 26.46 |
| Total Income From Operations | 4381.92 | 3497.66 | 3107.09 | 3387.24 | 3153.66 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1307.98 | 1087.82 | 938.87 | 1072.09 | 1047.32 |
| Purchase of Traded Goods | 825.70 | 376.85 | 260.38 | 282.90 | 307.04 |
| Increase/Decrease in Stocks | -126.27 | -101.70 | 14.45 | -36.10 | -107.96 |
| Employees Cost | 782.31 | 706.41 | 649.18 | 603.95 | 550.96 |
| Depreciation | 224.97 | 204.83 | 178.52 | 165.79 | 156.24 |
| Other Expenses | 945.37 | 986.39 | 805.72 | 669.74 | 612.90 |
| Total Expenses | 3960.06 | 3260.59 | 2847.12 | 2758.36 | 2566.49 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 421.87 | 237.06 | 259.97 | 628.88 | 587.17 |
| Other Income | 118.81 | 138.26 | 125.35 | 132.68 | 111.91 |
| P/L Before Interest, Excpt. Items & Tax | 540.67 | 375.32 | 385.32 | 761.56 | 699.08 |
| Interest | 112.96 | 166.09 | 166.83 | 145.14 | 123.34 |
| P/L Before Exceptional Items & Tax | 427.71 | 209.23 | 218.48 | 616.42 | 575.74 |
| Exceptional Items | 0.00 | -9.32 | -6.15 | 0.00 | -18.29 |
| P/L Before Tax | 427.71 | 199.91 | 212.34 | 616.42 | 557.45 |
| Tax | 110.58 | 39.08 | 52.28 | 169.61 | 136.97 |
| P/L After Tax from Ordinary Activities | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| Net Profit/Loss For the Period | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| | | | | | |
| Equity Share Capital | 189.48 | 181.15 | 180.85 | 180.85 | 180.85 |
| Reserves And Surplus | 2834.88 | 1753.95 | 1661.02 | 1531.68 | 2120.92 |
| Equity Dividend Rate | 0.00 | 30.00 | 20.00 | 10.00 | 10.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| Diluted EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| Diluted EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| | | | | | |
| PBITOE Margin (%) | 9.62 | 6.77 | 8.36 | 18.56 | 18.61 |
| PBTE Margin (%) | 9.76 | 5.98 | 7.03 | 18.19 | 18.25 |
| PBT Margin (%) | 9.76 | 5.71 | 6.83 | 18.19 | 17.67 |
| PAT Margin (%) | 7.23 | 4.59 | 5.15 | 13.19 | 13.33 |